(Q73449534)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10675112%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Progressive forms of MS: classification streamlined or consensus overturned? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10675112%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

B G Weinshenker

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10675112%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

English

0 references

publication date

1 January 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10675112%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10675112%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

355

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10675112%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

9199

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10675112%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

162-163

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10675112%20AND%20SRC:MED&resulttype=core&format=json

Studies on the natural history of multiple sclerosis--8. Early prognostic features of the later course of the illness

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900356-6

7 January 2021

The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900356-6

7 January 2021

Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900356-6

7 January 2021

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900356-6

7 January 2021

Defining the clinical course of multiple sclerosis: Results of an international survey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900356-6

7 January 2021

Primary progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900356-6

7 January 2021

Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900356-6

7 January 2021

Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900356-6

7 January 2021

The natural history of multiple sclerosis: a geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900356-6

7 January 2021

Multiple sclerosis that is progressive from the time of onset: clinical characteristics and progression of disability

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900356-6

7 January 2021

Axonal transection in the lesions of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900356-6

7 January 2021

Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900356-6

7 January 2021

Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900356-6

7 January 2021

A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900356-6

7 January 2021

Multiple sclerosis: lessons from neuropathology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900356-6

7 January 2021

A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900356-6

7 January 2021

10.1016/S0140-6736(99)00356-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10675112%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference